Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2661 – 2680 of 3231

Baseline Evaluation

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/baseline-evaluation

Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-between-nnrtis-pis

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/overview-2

Drug-Drug Interactions: Integrase Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors or Protease Inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-between-instis-nnrtis-pis

Didanosine (Videx, ddI)

https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-didanosine-videx

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/toxoplasmosis

Special Populations: Women With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-women-hiv

Antiretroviral Therapy to Prevent Sexual Transmission of HIV (Treatment as Prevention)

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/arv-therapy-as-prevention

Microsporidiosis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/microsporidiosis

Bacterial Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/bacterial-infections

Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/common-or-serious-adverse-reactions

Drug-Drug Interactions: Non-Nucleoside Reverse Transcriptase Inhibitors and Other Drugs

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-nnrti

Hepatitis B Virus Infection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/hepatitis-b-virus

Primary HIV Infection

https://clinicalinfo.hiv.gov/glossary/primary-hiv-infection

https://clinicalinfo.hiv.gov/node/9499

AIDS Encephalopathy

https://clinicalinfo.hiv.gov/glossary/aids-encephalopathy

Demencia relacionada con el VIH (DAV)

https://clinicalinfo.hiv.gov/glossary/aids-encephalopathy

HIV Encephalopathy

https://clinicalinfo.hiv.gov/glossary/hiv-encephalopathy

Encefalopatía causada por el SIDA

https://clinicalinfo.hiv.gov/glossary/hiv-encephalopathy

HIV-Associated Dementia (HAD)

https://clinicalinfo.hiv.gov/glossary/hiv-associated-dementia-had